Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Tejas Shah

Vascular Surgery Downers Grove, IL Medical Doctor

NPI 1326243171 CMS profile 1325954

3825 Highland Ave Fl Tower24, Downers Grove, IL 60515

Open in the dashboard

General payments

$213,209

480 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Tejas Shah of Downers Grove, IL is reported in the CMS Open Payments database as having received $213,209 across 480 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 97th percentile of Vascular Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $94,467 133
2024 General $40,022 96
2023 General $23,427 58
2022 General $34,477 100
2021 General $8,931 31
2020 General $10,049 36
2019 General $1,837 26

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Tejas Shah
  • Vascular Surgery median
  • Middle half of Vascular Surgery
  • National median

In program year 2025, general payments to Tejas Shah were reported at $94,467. Among 3,991 Vascular Surgery profiles paid that year, the median was $924 and the middle half received between $273 and $2,636.

Show as a table
Year Tejas Shah Vascular Surgery median Middle half National median
2019 $1,837 $796 $226–$2,363 $163
2020 $10,049 $348 $118–$1,110 $114
2021 $8,931 $471 $158–$1,421 $132
2022 $34,477 $725 $222–$2,183 $149
2023 $23,427 $836 $257–$2,440 $160
2024 $40,022 $909 $252–$2,619 $164
2025 $94,467 $924 $273–$2,636 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Stryker Corporation $70,574 57 payments
  2. Integra LifeSciences Corporation $34,837 52 payments
  3. Inari Medical, Inc. $31,323 67 payments
  4. LeMaitre Vascular, Inc. $23,732 24 payments
  5. Cardiovascular Systems Inc. $16,115 26 payments
  6. Medtronic, Inc. $11,398 34 payments
  7. Bard Peripheral Vascular, Inc. $7,201 25 payments
  8. Abbott Laboratories $5,586 62 payments
  9. W. L. Gore & Associates, Inc. $3,738 30 payments
  10. Acell, Inc. $3,730 4 payments
  11. Other $4,976 99 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $136,725 52 payments
  2. Travel and Lodging $27,750 74 payments
  3. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $20,950 14 payments
  4. Food and Beverage $15,143 332 payments
  5. Compensation for serving as faculty or as a speaker for a medical education program $8,100 2 payments
  6. Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program $3,710 3 payments
  7. Education $831 3 payments
Products named General payments · program years 2019–2025
  1. CT THROMBECTOMY SYSTEM KIT $99,093 101 payments
  2. FLOWTRIEVER CATHETER, S $99,093 101 payments
  3. Integra Recon-Skin And Wound $22,417 43 payments
  4. Integra Recon-Skin And Wound $21,468 40 payments
  5. Diamondback Peripheral $16,115 26 payments
  6. HYDRO LEMAITRE VALVULOTOME $13,293 5 payments
  7. PRIMATRIX $10,137 28 payments
  8. HawkOne $9,375 12 payments
  9. INTEGRA WOUND MATRIX (THIN) $7,032 3 payments
  10. INTEGRA MESHED BILAYER WOUND MATRIX $7,032 3 payments
  11. Other $55,333 406 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 6 drugs

Part D claims

407

Median for Vascular Surgery: 122

Drug cost

$88,852

Median for Vascular Surgery: $14,135

Branded share of claims

93.1%

Median for Vascular Surgery: 71%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Eliquis Apixaban Brand 67 $54,713
Xarelto Rivaroxaban Brand 20 $16,539
Brilinta Ticagrelor Brand 24 $14,501
Clopidogrel Clopidogrel Bisulfate Brand 268 $3,048
Atorvastatin Calcium Generic 14 $35
Prednisone Generic 14 $16

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 3,087 Part D prescribers listed as Vascular Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 121 billing codes

Paid by Medicare

$252,051

Medicare's payments for the services billed

Medicare patients

418

Average age 75

Services billed

2,263

192 women, 226 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Ischemic heart disease 56%
Arthritis 54%
Chronic kidney disease 53%
Diabetes 50%
Heart failure 42%
Atrial fibrillation 35%
COPD 25%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

480 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Vascular Surgery in Illinois

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record